InvestSMART

Chrysos Corporation Limited (ASX:C79)

ALERT: Price-sensitive ASX Announcement for C79
Current share price for C79 : $5.810 -0.19 (-3.17%)+
Announcement
Release
4 Jun 2026 9:04AM
Price at Release
$6.000
Full Release
download
Summary
Chrysos Corporation Limited announced the execution of a new three-year AUD $200 million syndicated debt facility to replace its existing asset-based financing. This facility, provided by Australia and New Zealand Banking Group Limited, National Australia Bank Limited, and Export Finance Australia, offers improved debt pricing, reduced fees, and enhanced covenants, increasing funding flexibility by $105 million. The funds will support the manufacturing and global deployment of PhotonAssay™ units, with the aim of returning to a production cadence of 18 units per year. Chrysos continues to expand with 23 lease agreements signed year-to-date, reflecting strong market demand and operational momentum enhanced by the robust gold market.
Key Points
  • Chrysos Corporation Limited secured a $200 million syndicated facility.
  • The facility is for three years with three domestic financiers.
  • It replaces the existing asset-based financing with a corporate-style facility.
  • The facility allows for operational flexibility and supports global PhotonAssay™ unit deployment.
  • Financial flexibility is enhanced with increased funding headroom by $105 million.
  • The company plans to manufacture 18 units per year.
  • There are 22 PhotonAssay™ units and 27 long-lead components in the order book.
  • Chrysos signed 4 additional PhotonAssay™ lease agreements.
  • The debt facility will be utilized to extinguish the existing asset-based financing.
  • Chrysos achieved high utilization of PhotonAssay™ fleet due to a strong gold market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.